Hypertensive nephropathy risk factors

Hypertensive nephropathy Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Differentiating Hypertensive Nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Abdominal X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypertensive nephropathy risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypertensive nephropathy risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypertensive nephropathy risk factors
CDC on Hypertensive nephropathy risk factors
Hypertensive nephropathy risk factors in the news
Blogs on Hypertensive nephropathy risk factors
Directions to Hospitals Treating Hypertensive nephropathy
Risk calculators and risk factors for Hypertensive nephropathy risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Risk Factors

• APOL1 gene
  • This gene has been identified to accelerate the progression of renal disease in African- American hypertensive patients.
• The Framingham heart study showed that a combination of hypertension with mild reduction in glomerular filtration rate was a risk factor for development of chronic renal insufficiency.
• Diabetes, smoking, obesity and high levels of low density lipoproteins also contribute to the progression of renal damage secondary to hypertension.